Plenaxis and Hypoaesthesia - a phase IV clinical study of FDA data
No or few reports are found.
The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
No or few reports are found.
What is Plenaxis?
Plenaxis has active ingredients of abarelix. Currently, eHealthMe is studying from 68 Plenaxis users.
What is Hypoaesthesia?
Hypoaesthesia (reduced sense of touch or sensation) is found to be associated with 3,601 drugs and 3,171 conditions by eHealthMe. Currently, we are studying 179,856 people who have Hypoaesthesia.
Do you take Plenaxis and have Hypoaesthesia?Check whether Hypoaesthesia is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Plenaxis side effects by duration, gender and age:
- Plenaxis side effects (68 reports)
Hypoaesthesia treatments and more:
- Hypoaesthesia (179,856 reports)
All the drugs that are associated with Hypoaesthesia:
All the conditions that are associated with Hypoaesthesia:
How the study uses the data?
The study uses data from the FDA. It is based on abarelix (the active ingredients of Plenaxis) and Plenaxis (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Demadex and Escitalopram drug interaction - 5 seconds ago
- Novolog and Haematocrit Decreased - 10 seconds ago
- Heparin-Fraction, Sodium Salt and Ibu drug interaction - 10 seconds ago
- Comtan and Femoral Neck Fracture - 20 seconds ago
- Augmentin '125' and Respiratory Distress - 27 seconds ago
- Velcade and Intestinal Haemorrhage - 29 seconds ago
- Cephalexin and Isopto Atropine drug interaction - 29 seconds ago
- Celecoxib and Diazoxide drug interaction - 31 seconds ago
- Folic Acid and Broken Bone - 31 seconds ago
- Metolazone and Enzalutamide drug interaction - 33 seconds ago